-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Blog
In the endemic, yet doctors will continue seeing you virtually
Oct 26, 2022
The COVID-19 pandemic has undoubtedly disrupted communication channels including the healthcare companies engagement model as healthcare professionals (HCPs) have been getting more comfortable with virtual engagement. In our last Southeast Asia (SEA) WellTrack 2 study in 2021, it revealed that HCPs want a hybrid form of engagement from healthcare companies. In today’s new normal, our latest WellTrack 3 findings have confirmed that digital engagement continues to thrive despite the fact that face-to-face communication have resumed in the endemic.
Higher preference on digital interaction
Face-to-face engagement has gained high preference among HCPs especially in activities which require material sharing and interaction such as product detailing. However, HCPs have fully adopted and shown higher preference for virtual forms of detailing such as video, chat and remote detailing platforms compared to the pre-pandemic period. We also observe the rise of new communication formats such as webinar, online HCP chat groups and online postgrad/continuing medical education (CME).
This is thanks to a number of initiatives from healthcare companies such as investing in digital engagement platforms, shortening and sharpening the content and enhancing the skill set of medical representatives, which have contributed into enhancing the experience with healthcare professionals. In the context of hybrid forms of engagement, it is crucial to develop the right touch points in order to maximize the effectiveness. Detailing content is also critical to impress HCPs within the ideal detailing length of lesser than 20 minutes to stand out from competitors.
One size does not fit all
However, one size doesn’t fit all across the markets in Southeast Asia. Our WellTrack 3 findings observe different adoption speed of digital engagement by HCPs across the region.
- Vietnam is one of the countries which has shown the fastest adoption in digitalization. Compared to pre-pandemic period, detailing via chat and video platform have raised preference by 6% and now is head-to-head with in-person communication. Video detailing is anticipated to surpass in-person detailing in terms of preference by 5%.
- Malaysia HCPs significantly prefer detailing via video call (+16%), remote detailing platform (+20%) and HCP social networks (+14%) versus pre-pandemic. Uniquely, Malaysia also records the interest in detailing via text than other SEA countries.
- Top 3 growing virtual channels of Indonesian HCPs are online round table discussion (+5%), detailing via text (+3%) and video calls (+3%). Face-to-face product detailing has reduced in preference by 19% versus pre-pandemic and now stays on par with digital detailing.
- Philippines HCPs have resumed the same preference of in-person detailing as that of before the pandemic. However, HCPs fully support the virtual engagement mode with significantly higher preference on a number of virtual touch points such as webinar, webcast, online round table discussion, online chat groups with other doctors, online postgrad/CME, detailing via video, chat and text platforms.
- While HCPs in Singapore and Thailand have well adapted to virtual engagement modes, they have also shown higher preference for face-to-face detailing compared to pre-pandemic. HCPs seem to be open for more interactions with the hybrid model. Singapore HCPs especially have shown remarkable preference in HCP social networks (+21%) while Thailand HCPs are keen on detailing via phone call (+12%).
As the hybrid model remains to be well-established in HCP engagement, the next question for healthcare companies is: How can you develop the right communication strategy with the right channels and the right content? Identifying HCP digital preferences is just the beginning. It is crucial to also investigate the right kind of content and topic for each mode of engagement as well as understand unmet HCP needs and challenges to provide a more holistic view of this digital journey.
With these insights, healthcare companies can craft an effective strategy and leverage 360 degree maturity solutions to design the best engagement scheme with HCPs, emerge stronger and stay ahead in the ever-evolving landscape. To learn more information about WellTrack data and trends across markets, categories and stakeholders, please feel free to contact us here.
Consumers have also shown mixed changes in their purchasing behaviours and attitudes towards Consumer Health products in the post-pandemic era – click here to learn more.